Randomized, Crossover Study of the Pharmacodynamic Activity of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Characterized by Low Tear Volume
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2017
At a glance
- Drugs SHP-659 (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors Parion Sciences
- 02 Jun 2017 Status changed from recruiting to discontinued.
- 03 Oct 2016 Status changed from not yet recruiting to recruiting.
- 01 Jul 2016 Status changed from planning to not yet recruiting.